Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The lens and PUVA therapy.

C C Sterk, C A Geldof, H G Ten-Jet-Foei

    Documenta Ophthalmologica. Advances in Ophthalmology
    |February 28, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Photochemotherapy (PUVA) for psoriasis showed minimal risk of lens abnormalities. A study of 42 patients found only one instance of slight opacity possibly linked to PUVA treatment.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Late ophthalmological complications after total body irradiation in non-human primates.

    International journal of radiation biology·2001
    Same author

    [Towards an accreditation system for the Dutch hospitals].

    Nederlands tijdschrift voor geneeskunde·1999
    Same author

    The effect of 1% apraclonidine on intraocular pressure after cataract surgery.

    Ophthalmic surgery and lasers·1998
    Same author

    Decreased basal tear turnover in patients with untreated primary open-angle glaucoma.

    American journal of ophthalmology·1995
    Same author

    Is glaucoma associated with an increased risk of cataract?

    The British journal of ophthalmology·1995
    Same author

    Recurrent herpetic keratitis in penetrating keratoplasty.

    Documenta ophthalmologica. Advances in ophthalmology·1995

    Area of Science:

    • Ophthalmology
    • Dermatology
    • Photobiology

    Background:

    • Psoriasis is a chronic autoimmune condition requiring treatments like PUVA therapy.
    • PUVA therapy involves psoralen and ultraviolet A radiation, raising questions about ocular side effects.
    • Ocular health monitoring is crucial for patients undergoing long-term phototherapy.

    Purpose of the Study:

    • To investigate the potential occurrence of lens abnormalities in patients undergoing PUVA therapy for psoriasis.
    • To assess the safety of PUVA treatment concerning long-term ocular health.
    • To determine if PUVA therapy is associated with the development of cataracts or other lens opacities.

    Main Methods:

    • A cohort of 42 patients with psoriasis receiving PUVA therapy was recruited.

    Related Experiment Videos

  • Ophthalmic examinations were conducted to detect any lens abnormalities.
  • Patient data was analyzed to correlate potential findings with PUVA treatment duration and dosage.

    • Main Results:

    • Out of 42 patients, only one patient exhibited a very slight lens opacity.
    • This opacity was considered a possible, but not definitive, consequence of PUVA therapy.
    • No significant or widespread lens abnormalities were detected in the study group.

    Conclusions:

    • PUVA therapy for psoriasis appears to have a low risk of causing significant lens abnormalities.
    • The observed slight opacity in one patient warrants further investigation but does not indicate a high risk.
    • Ocular safety monitoring in PUVA-treated patients should continue, but the findings suggest minimal ocular impact.